Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study
Skin Carcinoma
About this trial
This is an interventional prevention trial for Skin Carcinoma
Eligibility Criteria
Inclusion Criteria:
- Have undergone autologous or allogeneic hematopoietic stem cell transplantation (HCT) at City of Hope (COH)
- Are 2 years (yrs) to 5 yrs (+/- 3 months [m]) after HCT
- Have seen a primary care provider (PCP) in the previous 12 m (expected > 95% of all eligible) or planning to do so in next 12 m
- Have a mobile phone with the ability to receive text messages
- Can fluently read and write in English or Spanish
- Can understand and sign the study-specific Informed Consent Form (ICF)
Exclusion Criteria:
- Patients who have evidence of active hematologic malignancy or acute illness that would limit study participation
Sites / Locations
- City of Hope Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Group I (PAE)
Group II (PAE, physician)
Group III (PAE, physician, dermatoscope)
Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months.
Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months. Participants' physician receives a letter that describes the educational intervention and encourages them to do a skin examination at next patient visit.
Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months. Participants' physician receives a letter that describes the educational intervention and encourages them to do a skin examination at next patient visit. Physicians also receive a free dermatoscope with instructions for uploading images of suspect lesions and attend a 30-minute online course comprising additional descriptions of dermoscopic images for skin cancers and "mimickers" common in hematopoietic stem cell transplantation patients, along with clear instructions for using a dermatoscope and steps to integrate dermoscopy into their practice.